Adenomyosis and Pregnancy: Levonorgestrel vs. GnRH for Blastocyst Transfer

NACompletedINTERVENTIONAL
Enrollment

184

Participants

Timeline

Start Date

December 15, 2023

Primary Completion Date

April 10, 2024

Study Completion Date

July 1, 2024

Conditions
Adenomyosis
Interventions
DRUG

Triptorelin

GnRHa will be given as a subcutaneous injection of triptorelin in a dose of 3.75 mg monthly for three months.

DEVICE

levonorgestrel-releasing intrauterine system

The levonorgestrel-releasing intrauterine system releasing 20 levonorgestrel daily.

PROCEDURE

frozen embryo transfer

"Frozen embryo transfer (FET) where a previously frozen embryo is thawed and transferred into a woman's uterus.~The FET process involves hormone preparation to prepare the uterus for the transfer, embryo thawing, and the actual transfer of the embryo into the uterus. If the embryo implants and develops successfully, pregnancy can occur."

Trial Locations (1)

44519

Zagazig university, Zagazig

All Listed Sponsors
lead

Zagazig University

OTHER_GOV

NCT06581679 - Adenomyosis and Pregnancy: Levonorgestrel vs. GnRH for Blastocyst Transfer | Biotech Hunter | Biotech Hunter